Jump to content

Harrison Stafford

Legacy Members
  • Posts

    2911
  • Joined

  • Last visited

Everything posted by Harrison Stafford

  1. The FDA statement suggests they want to help IBRX gain approvals as quickly as possible. Without sounding like too much of a “homer”, I think they believe PSS is on to something. Of course, chemo and radiation patients would be a huge market.
  2. We are a >much< better rebounding team with Jabari Smith in the lineup. Hey la day la Jabari’s back.
  3. https://immunitybio.com/immunitybio-receives-fda-rmat-designation-for-anktiva-and-car-nk-for-the-reversal-of-lymphopenia-in-patients-receiving-standard-of-care-chemotherapy-radiotherapy-and-in-treatment-of-multiply-rel/ And this just in re: IBRX
  4. This smacks of ETF liquidation. Hoping this isn’t the beginning of a bear mkt...in which case the pain is just getting started.
  5. The sp of both IBRX & GERN is lower than it was before both companies had cancer drugs approved by the FDA. Madness.
  6. Screw it. Bought 6000 shares of GERN at 1.63 to avg down. Rytelo is selling and trials are enrolling apace. Blood banks are less stressed and patients are living transfusion-free. BP needs to buy this company soon so I can make a little coin and close this position.
  7. GERN 6000 shrs at 3.19. Considering another 6000 shares to avg down. Given their earnings, I don’t understand what the mkt sees that I don’t. Going to try and find an explanation…which will most likely be a waste of time. GERN has been the bane of my existence since 2013. I fucking hate this stock. RVPH 15,000 shrs at 6.64. Bought 5000 today at 1.39 to avg down.
  8. IRBT. The entire market’s been getting slammed. It’s not stock specific.
  9. I have no problem selling for a profit in the teens. The company’s half the size it was when Amazon was bidding for them. However, if the turn around guy, the new CEO, is successful the sp could go higher. I’m definitely looking for more than break even.
  10. Touring in the late 70’s and 80’s, Bobby Caldwell would trip out a good portion of both black and white members of the audience who thought he was black. Bigtime blue-eyed soul.
  11. Bought another 1000/sh IRBT at 7.48 bringing down the avg.
  12. This is Ole (Oh-Lee). He was named after Olaf, the snowman in the Disney movie Frozen. I wanted to name him Blanco, but was outvoted….by my granddaughters…I never stood a chance. Ten years ago, my wife’s consulting job required a fair amount of travel and she was worried about me being at home by myself. Our three kids were all out of college and lived out of town. So, she decided we needed a dog. Specifically, I needed a dog for companionship when she was away. I told her I was fine and didn’t need a dog, but she was undeterred….as wives can be. Within a week, she goes to a Poodle rescue shelter and brings home Ole. Don’t let the “Poodle”in Ole or his unassuming appearance fool you. Ole is fast as shit. He catches squirrels. He doesn’t hurt them. He just wants to play with ‘em and, over time, the squirrels at the Stafford Estate have come to understand that it’s just a game for Ole, so the squirrels play along. In fact, the squirrels will lie spread eagle on the sidewalk outside the kitchen window waiting for Ole to see them, so he’ll come outside to play. Over the past several years, my wife has been out of state up to a month at a time to take care of her ailing parents. I don’t know what I’d do without Ole.
  13. You’ve been bad to me woman but it’s coming back home to you
  14. Here you go. In addition, the European Medicines Agency accepted IBRX’s application of Anktiva for the treatment of patients with bladder cancer. This application covers 30 countries in the EU. Now, just waiting on approval. Big Pharma (looking at you, Merck) will most def try to buy IBRX at a hefty premium. Patrick Soon-Shiong, who owns 80% of IBRX, is 72 years old and ain’t getting any younger. Hit him with an uber aggressive offer and he might just bite. PSS also has the track record of building up a company and selling to big Pharma for big bucks.
  15. While we’re on the subject.
  16. *When* it goes to 30.
  17. Bought 5,000 shares of IBRX at $3.58 bringing the position to 32,800 shares and moving the avg down from $9.77 to $8.85.
  18. Does he cross himself before every massage?
  19. Goo-goo g’joob.
  20. If we keep this guy, it tells you we aren’t serious about winning a national championship in men’s hoops.
  21. Since selling EOSE and, actually, making money and having liquidity, I’m buying another 5,000 shares of IBRX on a pullback…somewhere south of $3.60. That will increase my position to 32,800 shares and bring down that $9.77 avg. And Happy Valentine’s Day to my fellow long-suffering bastards. Wishing you all a profitable year!
×
×
  • Create New...